Because PLK1 is highly expressed in cancer cells and is associated with the poor prognosis of many cancers, it has emerged as a new target for developing many anticancer drugs (Li Z. et al., 2020; Yu et al., 2021). This evidence concerns the gene PLK1 and cancer.